BIO-TECHNE Corp Acquisitions, Net of Cash Acquired
BIO-TECHNE Corp (TECH) reported Acquisitions, Net of Cash Acquired of $0 for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-24
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for the quarter ending 2025-03-31 was $0.00.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for the quarter ending 2024-06-30 was $0.00.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for the quarter ending 2024-03-31 was $0.00.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $3.28M.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for fiscal 2024 was $169.71M, a 67.72% increase from fiscal 2023.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for fiscal 2023 was $101.18M.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for fiscal 2021 was $225.35M.
- BIO-TECHNE Corp payments to acquire businesses, net of cash acquired for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $0.00 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $0.00 10-Q · filed 2025-02-06 | ||||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $0.00 derived: sum of 2 quarters · filed 2026-08-24 | $3.28M derived: sum of 3 quarters · filed 2026-08-24 | $169.71M 10-K · filed 2026-08-24 | |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $3.28M derived: sum of 2 quarters · filed 2025-05-08 | $169.71M 10-Q · filed 2025-05-08 | $169.71M derived: sum of 4 quarters · filed 2025-08-22 | |
| 2023-12-31 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | $169.71M 10-Q · filed 2025-02-06 | $169.71M derived: sum of 3 quarters · filed 2025-08-22 | $169.71M derived: sum of 4 quarters · filed 2025-08-22 | |
| 2023-09-30 | $166.43M 10-Q · filed 2024-11-05 | $166.43M derived: sum of 2 quarters · filed 2025-08-22 | $166.43M derived: sum of 3 quarters · filed 2025-08-22 | $166.43M derived: sum of 4 quarters · filed 2025-08-22 | |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $0.00 derived: sum of 2 quarters · filed 2025-08-22 | $0.00 derived: sum of 3 quarters · filed 2025-08-22 | $101.18M 10-K · filed 2025-08-22 | |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $0.00 derived: sum of 2 quarters · filed 2024-05-06 | $101.18M 10-Q · filed 2024-05-06 | ||
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $101.18M 10-Q · filed 2024-02-07 | |||
| 2022-09-30 | $101.18M 10-Q · filed 2023-11-07 | ||||
| 2021-12-31 | $0.00 10-Q · filed 2022-02-07 | ||||
| 2021-06-30 | $215.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $215.59M derived: sum of 2 quarters · filed 2023-08-23 | $225.35M 10-K · filed 2023-08-23 | ||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $9.77M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $9.77M 10-Q · filed 2022-02-07 | ||||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $0.00 derived: sum of 2 quarters · filed 2021-08-25 | $0.00 derived: sum of 3 quarters · filed 2021-08-25 | $0.00 10-K · filed 2021-08-25 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-05-07 | $0.00 10-Q · filed 2021-05-07 | $17.21M derived: sum of 4 quarters · filed 2021-08-25 | |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $0.00 10-Q · filed 2021-02-08 | $17.21M derived: sum of 3 quarters · filed 2021-08-25 | $17.20M derived: sum of 4 quarters · filed 2021-08-25 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $17.21M derived: sum of 2 quarters · filed 2021-08-25 | $17.20M derived: sum of 3 quarters · filed 2021-08-25 | $17.26M derived: sum of 4 quarters · filed 2021-08-25 | |
| 2019-06-30 | $17.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $17.20M derived: sum of 2 quarters · filed 2021-08-25 | $17.26M derived: sum of 3 quarters · filed 2021-08-25 | $289.49M 10-K · filed 2021-08-25 | |
| 2019-03-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $57.00K derived: sum of 2 quarters · filed 2020-05-11 | $272.29M 10-Q · filed 2020-05-11 | $275.07M derived: sum of 4 quarters · filed 2020-08-26 | |
| 2018-12-31 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $272.29M 10-Q · filed 2020-02-06 | $275.07M derived: sum of 3 quarters · filed 2020-08-26 | $329.49M derived: sum of 4 quarters · filed 2020-08-26 | |
| 2018-09-30 | $272.23M 10-Q · filed 2019-11-06 | $275.01M derived: sum of 2 quarters · filed 2020-08-26 | $329.44M derived: sum of 3 quarters · filed 2020-08-26 | $329.45M derived: sum of 4 quarters · filed 2020-08-26 | |
| 2018-06-30 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $57.21M derived: sum of 2 quarters · filed 2020-08-26 | $57.22M derived: sum of 3 quarters · filed 2020-08-26 | $67.85M 10-K · filed 2020-08-26 | |
| 2018-03-31 | $54.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $54.43M derived: sum of 2 quarters · filed 2019-05-07 | $65.07M 10-Q · filed 2019-05-07 | $64.91M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2017-12-31 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $10.64M 10-Q · filed 2019-02-07 | $10.49M derived: sum of 3 quarters · filed 2019-11-06 | $8.50M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2017-09-30 | $10.63M 10-Q · filed 2018-11-07 | $10.48M derived: sum of 2 quarters · filed 2019-11-06 | $10.63M 10-Q · filed 2017-11-09 | $11.23M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2017-06-30 | -$156.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | -$2.14M derived: sum of 2 quarters · filed 2019-11-06 | $592.00K derived: sum of 3 quarters · filed 2019-11-06 | $253.78M 10-K/A · filed 2019-11-06 | |
| 2017-03-31 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $748.00K derived: sum of 2 quarters · filed 2018-05-09 | $253.94M 10-Q · filed 2018-05-09 | $254.48M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-12-31 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $255.93M 10-Q · filed 2018-02-08 | $256.46M derived: sum of 3 quarters · filed 2018-08-27 | $264.46M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-09-30 | $253.19M 10-Q · filed 2017-11-09 | $259.00M 10-Q · filed 2016-11-09 | $253.73M derived: sum of 2 quarters · filed 2018-08-27 | $253.19M 10-Q · filed 2017-11-09 | $261.65M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-06-30 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $8.54M derived: sum of 2 quarters · filed 2018-08-27 | $8.45M derived: sum of 3 quarters · filed 2018-08-27 | $91.42M 10-K · filed 2018-08-27 | |
| 2016-03-31 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $7.92M derived: sum of 2 quarters · filed 2017-05-10 | $90.89M 10-Q · filed 2017-05-10 | $90.89M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-12-31 | -$82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $82.89M 10-Q · filed 2017-02-09 | $82.89M derived: sum of 3 quarters · filed 2017-09-07 | $82.89M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-09-30 | $82.97M 10-Q · filed 2016-11-09 | $82.97M derived: sum of 2 quarters · filed 2017-09-07 | $82.97M derived: sum of 3 quarters · filed 2017-09-07 | $142.90M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $0.00 derived: sum of 2 quarters · filed 2017-09-07 | $59.93M derived: sum of 3 quarters · filed 2017-09-07 | $420.10M 10-K · filed 2017-09-07 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $59.93M derived: sum of 2 quarters · filed 2016-05-10 | $420.10M 10-Q · filed 2016-05-10 | $426.13M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-12-31 | $59.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $420.10M 10-Q · filed 2016-02-09 | $426.13M derived: sum of 3 quarters · filed 2016-08-29 | $426.13M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-09-30 | $360.18M 10-Q · filed 2015-11-09 | $366.21M derived: sum of 2 quarters · filed 2016-08-29 | $366.21M derived: sum of 3 quarters · filed 2016-08-29 | $366.31M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-06-30 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $6.03M derived: sum of 2 quarters · filed 2016-08-29 | $6.13M derived: sum of 3 quarters · filed 2016-08-29 | $109.18M 10-K · filed 2016-08-29 | |
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $100.00K derived: sum of 2 quarters · filed 2015-05-11 | $103.15M 10-Q · filed 2015-05-11 | $103.15M derived: sum of 4 quarters · filed 2015-08-31 | |
| 2013-12-31 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | $103.15M 10-Q · filed 2015-02-09 | $103.15M derived: sum of 3 quarters · filed 2015-08-31 | $103.15M derived: sum of 4 quarters · filed 2015-08-31 | |
| 2013-09-30 | $103.05M 10-Q · filed 2014-11-10 | $103.05M derived: sum of 2 quarters · filed 2015-08-31 | $103.05M derived: sum of 3 quarters · filed 2015-08-31 | $103.05M derived: sum of 4 quarters · filed 2015-08-31 | |
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $0.00 derived: sum of 2 quarters · filed 2015-08-31 | $0.00 derived: sum of 3 quarters · filed 2015-08-31 | $0.00 10-K · filed 2015-08-31 | |
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2014-05-12 | $0.00 10-Q · filed 2014-05-12 | ||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | $0.00 10-Q · filed 2014-02-04 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | ||||
| 2012-06-30 | $0.00 10-K · filed 2014-08-29 | ||||
| 2011-06-30 | $131.77M 10-K · filed 2013-08-29 | ||||
| 2010-06-30 | $0.00 10-K · filed 2012-08-29 | ||||
| 2009-06-30 | $0.00 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |